NCT04708301View on ClinicalTrials.gov

Characterisation of Heart Involvement in Fabry Disease With T1 Mapping

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

March 12, 2014

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Fabry Disease
Interventions
DIAGNOSTIC_TEST

T1 mapping

T1 mapping is a specialised heart scan that measures the magnetic properties of heart tissue and displays them as an image or map

Trial Locations (1)

M239LT

Manchester Univiersty Foundation Trust, Manchester

All Listed Sponsors
collaborator

Northern Care Alliance NHS Foundation Trust

OTHER

lead

Manchester University NHS Foundation Trust

OTHER_GOV

NCT04708301 - Characterisation of Heart Involvement in Fabry Disease With T1 Mapping | Biotech Hunter | Biotech Hunter